Good results of IceCure’s kidney cancer solution
Israel’s IceCure (see previously) is already saving many lives by destroying tumors using cryoablation (freezing). Its most recent ICESECRET study on 114 kidney cancer patients with small renal masses (SRM) showed an 88.7% non-reoccurrence rate.
If you’re sick, see a computer
A new study from Tel Aviv University found that diagnoses and treatment recommendations given by AI were more accurate than those of physicians. Of 461 online patient visits, AI was rated as good in 77% of cases but only 67% by doctors. Bad AI ratings were 2.8%; Bad doctors were at 4.6%.
Israel’s first psycho-trauma dog unit
Israeli medical emergency NGO United Hatzalah has just completed training it Psycho-trauma Canine Unit. Its 10 special dogs provide support until the ambulance arrives. Leading Israeli pet supply chain, Speedog, will donate a portion of sales proceeds, plus essential equipment and food.
Complex facial surgery for Guatemalan baby
Santiago, a baby from Guatemala born with a cleft lip and palate (and other problems), successfully underwent complex corrective surgery at Israel’s Schneider Children's Medical Center. The parents knew in advance of Santiago’s condition and arranged to have their baby in Israel.
Brain cancer treatment trial
The radiation treatment from Israel’s Alpha Tau (see previously) has been used to treat skin cancer, prostate cancer, pancreatic cancer, liver cancer, and lung cancer. It now has had US FDA approval to initiate a trial for patients with recurrent glioblastoma (brain cancer).
Blood test for early detection of Parkinson’s
A team led by Hebrew University of Jerusalem researchers has developed the first ever blood test capable of detecting Parkinson’s disease, even before symptoms emerge. The test identifies transfer RNA fragments unique to the neurodegenerative disease.
Good progress on pancreatic cancer treatment
Israel’s Silexion Therapeutics reported that its SIL-204 pancreatic cancer treatment effectively reduces primary tumor growth and secondary cancer spread. Silexion 's first generation LODER treatment already had good results in Phase 2 trials on “simple” cancers.
From cultivated meat to muscle therapy
Israel’s Profuse (see previously) which specializes in the laboratory cultivation of muscle tissue for non-animal meat, has launched a new technology and program for preventing and restoring muscle lost by the growing use of weight-loss treatments, aging, and cancer.
Rehabilitation conference
Israel hosted the “Lifetime Partnership” International Rehabilitation Conference in Tel Aviv. It attracted medical and rehabilitation experts from militaries, defense ministries, and health departments in England, Thailand, Germany, Hungary, the Czech Republic, Brazil and Canada.
Combining complementary and conventional medicine
Israel’s Treat Me (see ) has developed an AI-driven platform that allows practitioners to create tailor-made treatment plans that bridge Western medicine, complementary therapies (e.g. Chinese medicine, naturopathy, reflexology) and cutting-edge research.